Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1105464

registered interest
date	27/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the statement in the NHS Long Term Plan that four-week waiting times for adult and older adult community mental health teams including for eating disorders will be tested with selected local areas, what the timetable is for those targets to be introduced; and whether funding will be allocated to areas to support these tests.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	237693
answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>The NHS Long Term Plan commits to “test four-week waiting times for adult and older adult community mental health teams, with selected local areas”.</p><p> </p><p>The ‘Clinically-led Review of NHS Access Standards’ Interim Report, published in March 2019, states that NHS England will test four-week waiting times for adult and older adult community mental health teams with selected local areas. As part of this work, the report states that NHS England will “consider the interfaces with specialist community mental health services, particularly where there is an existing evidence base for rapid direct access, such as adult eating disorder services, or early intervention in psychosis services, for which there is already a national access and waiting time standard in place.”</p><p> </p><p>The interim report sets out the initial proposals for testing changes to access standards in mental health services, cancer care, elective care and urgent and emergency care. The proposals will be field tested at a selection of pilot sites across England, before wider implementation. The information gathered through field testing and engagement will inform final recommendations from this Review, and ahead of full implementation beginning spring 2020.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 04/04/2019 14:48:09 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4433 label Biography information for Thangam Debbonaire

1105474

registered interest
date	27/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prosthetics: Recycling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department provides to hospitals on the recycling of parts from prosthetic limbs.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	237697
answer	answer is ministerial correction date of answer 03/04/2019 answer text <p>Prosthetic limbs provided by NHS Limb Centres are bespoke which limits their reusability; whilst individual services may have their own arrangements in place for recycling parts, NHS England and the Department do not issue guidance on this.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 03/04/2019 11:19:01 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4433 label Biography information for Thangam Debbonaire

1087041

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the PACE trial of therapies on reducing the effects of (a) myalgic encephalomyelitis and (b) chronic fatigue syndrome.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	231512
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>The PACE trial, undertaken by Queen Mary University of London, was the largest ever trial of therapies for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). The trial aimed to test and compare the effectiveness of four of the main treatments available for people CFS/ME. These were adaptive pacing therapy, cognitive behaviour therapy (CBT), graded exercise therapy, and standardised specialist medical care (SMC).</p><p> </p><p>The five-year trial involved over 600 participants, aged 18 and over, in Scotland and England. The first set of results from the trial were published in 2011 in the Lancet, and a number of other evaluations based on the trial have been published since. The trial results found both CBT and GET were moderately effective when provided alongside SMC and were better than adaptive pacing therapy or SMC alone in improving both symptoms and disability.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children’, sets outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition. The guideline recommends CBT and GET as appropriate treatments for mild to moderate CFS/ME, in line with the best available evidence.</p><p> </p><p>The NICE guideline acknowledges that there is no one form of treatment to suit every patient and that treatment and care should take into account the personal needs and preferences of the patient. Decisions concerning the appropriateness of treatments should be made on a case by case basis.</p><p> </p><p>On 20 September 2017, NICE announced its decision to undertake a full update of the guideline, following a review of the latest available evidence on the diagnosis and management of CFS/ME and a public consultation. New guidance is expected in October 2020. More information on this decision can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me" target="_blank">www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:33:27 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1087043

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health: Disadvantaged
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to allocate funding for the ten-year review of progress on reducing health inequalities since the publication of the report entitled Fair Society, Healthy Lives, published by Michael Marmot.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	231513
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>We have no current plans to allocate funding to the Institute of Health Equity and Health Foundation review of Fair Society, Healthy Lives. We look forward to seeing the review’s conclusions in February 2020. Reducing health inequalities remains a priority for the Department and is central to the NHS Long Term Plan and the Secretary of State’s prevention priority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/03/2019 16:24:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4433 label Biography information for Thangam Debbonaire

1064303

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the Health Education England phase two cancer workforce plan co-ordinates with the workforce implementation plan in the NHS Long Term Plan.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223778
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.</p><p> </p><p>My Rt. hon. Friend Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/02/2019 12:17:17 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1064309

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations he has received on alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the UK.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223789
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224533 question first answered 28/02/2019 11:47:48 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire

1064781

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radioisotopes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of a shortage of radioisotopes on the number of breast cancer diagnostic and treatment procedures.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	224533
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified one item of correspondence received since 1 August 2018 about alternative arrangements for breast cancer diagnostic and treatment procedures in the event that there is a shortage of radioisotopes in the United Kingdom. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p> </p><p>We fully recognise that radioisotopes are vitally important to many people in this country including breast cancer patients. HM Revenue and Customs already has a process to identify ‘urgent goods’, such as medical radioisotopes, requiring faster handling to move through customs and border checks promptly. The Department has well established processes to manage and mitigate the small number of medicines shortages that may arise due to manufacturing or distribution issues. These processes include radioisotopes used in breast cancer diagnostic and treatment procedures.</p><p> </p><p>From January 2019, it became a mandatory requirement that the pharmaceutical industry must report this information to the Department in a timely manner. Following notification and risk assessment, the Department’s medicine supply team will continue to work behind the scenes with relevant stakeholders and use a host of tools to help mitigate and prevent an issue from impacting patients including the consideration of alternative treatment options. The Department is not aware of any significant radioisotope shortages that are currently affecting breast cancer patients.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 223789 question first answered 28/02/2019 11:47:49 answering member 1585 label Biography information for Stephen Hammond
tabling member	4433 label Biography information for Thangam Debbonaire

1052234

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 December 2018 to Question 198805, what progress has been made on increasing the supply of Epipens; and if he will make a statement.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215243
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>Supplies of EpiPen and other adrenaline auto-injectors are currently available in volumes that are sufficient to meet United Kingdom requirements. The Department continues to work very closely with all the manufacturers of adrenaline auto-injectors and can confirm that the supply situation continues to improve going forward with further deliveries expected over the coming weeks. All patients who require an adrenaline auto-injector should now be able to obtain a device from their pharmacy.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:28:31 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052240

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bacteriophages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits of phage therapy for tackling antimicrobial resistance.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215244
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>The Department and the Wellcome Trust sponsored a strategic pipeline briefing into alternatives to antibiotics in 2015. The briefing reviewed the feasibility and potential clinical impact of alternatives to antibiotics, including bacteriophages, and considered approaches that were most likely to deliver new treatments in the next 10 years. The briefing concluded that bacteriophages were possible therapeutics, but too few were being progressed.</p><p> </p><p>The Government continues to invest in research into new and alternative treatments. While there has been increased investment and unprecedented levels of research collaboration on antimicrobial resistance, there are still relatively few projects looking at the use of bacteriophages.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:26:34 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052242

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to increase the level of investment and funding for training and employing NHS microbiologists on long term contracts to increase diagnostic capacity as part of the government strategy to tackle antimicrobial resistance.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215245
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’ includes the commitment to assess current and future workforce needs to ensure capability and capacity for strong infection prevention and control and antimicrobial stewardship. The assessment will cover a range of roles, including microbiology. The results of the assessment will be used to develop further workforce targets.</p><p> </p><p>The NHS England Long Term Plan makes the commitment to implement the human health aspects of the national action plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:29:36 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire